WHY WE NEED YOU
We’re challenging Tradies all around Australia to help raise vital funds for game-changing research. By hosting a Tradie Tea Party, you will help us build towards a breast cancer breakthrough and stop breast cancer taking the ones we love.
Working towards zero deaths by 2030:
Our mission is simple: stop deaths from breast cancer.
How? By identifying, funding and championing world-class research - research that will help us detect tumours earlier, improve treatment outcomes, and ultimately – save lives.
Impact of your fundraising
Could support a world-class research team to uncover how factors such as location, demographics and socio-economic conditions impact survival outcomes.
Could support a world-class research team to develop a personalised vaccine that will boost the body’s own immune system to eradicate breast cancer cells.
Could support a world-class research team to develop better predictive tests that detect the presence of resistant cancer cells well before they start to grow as a secondary cancer.
What funding means to our researchers
We have a number of ground-breaking research projects focused on tackling the biggest hurdles to save lives from breast cancer. Here are two of our researchers… With your urgent support, we can fund more.
PROFESSOR RICCARDO DOLCETTI
The University of Queensland, QLD Project title: Personalising immunotherapy for breast cancer.
A certain class of drugs that stimulate the immune system to attack cancer has shown promising results in previously untreatable cancers. However, at present, these drugs are only effective in a small number of breast cancers and may cause adverse immune reactions due to their lack of specificity. As such, there is a need to tailor tumour fighting immune responses.
To overcome these limitations, NBCF-funded Professor Riccardo Dolcetti has developed a method to identify the unique antigens expressed by each individual breast cancer that can be targeted with personalised immunotherapy – using parts of one’s immune system to target cancer. Ultimately, his works hope to lead to a clinically vaccine that boost the immune system to target the hardest to treat forms of breast cancer.